The company remains a pre-revenue shell with no operational leverage, evidenced by a $748.2K quarterly loss in 2026Q2 and a complete absence of core revenue generation.
| Sales/Revenue | 0 | - | - | - | - |
| Revenue Growth % | - | - | - | - | - |
| Cost of Goods Sold | 0 | - | - | - | - |
| COGS % of Revenue | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - |
| Operating Expenses | 1.34M | 748.91K | 523.97K | 6.84K | 578 |
| OpEx % of Revenue | - | - | - | - | - |
| Selling, General & Admin | 1.34M | 748.91K | 523.97K | 6.84K | 578 |
| SG&A % of Revenue | - | - | - | - | - |
| Research & Development | 0 | - | - | - | - |
| R&D % of Revenue | - | - | - | - | - |
| Other Operating Expenses | 0 | - | - | - | - |
| Operating Income | -1.34M | -748.91K | -523.97K | -6.84K | -580 |
| Operating Margin % | - | - | - | - | - |
| Operating Income Growth % | - | -42.93% | -7555.96% | -1080% | - |
| EBITDA | -82.32K | -748.91K | -523.97K | -6.84K | -2 |
| EBITDA Margin % | - | - | - | - | - |
| EBITDA Growth % | 85.85% | -42.93% | -7555.96% | -342100% | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 578 |
| EBIT | -82.32K | -748.91K | -523.97K | -6.84K | -578 |
| Net Interest Income | 2.8M | 5.13M | 3.03M | 0 | 0 |
| Interest Income | 2.8M | 5.13M | 3.03M | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 0 | - | - | - | - |
| Pretax Income | 1.46M | 4.38M | 2.5M | -6.84K | -578 |
| Pretax Margin % | - | - | - | - | - |
| Income Tax | 476.06K | 965.63K | 635.51K | 0 | 0 |
| Effective Tax Rate % | 32.56% | 22.04% | 25.39% | 0% | 0% |
| Net Income | 986.21K | 3.42M | 1.87M | -6.84K | -578 |
| Net Margin % | - | - | - | - | - |
| Net Income Growth % | -74.59% | 82.94% | 27385.02% | -1084.08% | - |
| Net Income (Continuing) | 986.21K | 3.42M | 1.87M | -6.84K | -578 |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.68 | 0.22 | 0.12 | -0.00 | 0.00 |
| EPS Growth % | -67.65% | 83.33% | - | - | - |
| EPS (Basic) | - | 0.22 | 0.12 | -0.00 | 0.00 |
| Diluted Shares Outstanding | 1.44M | 11.25M | 15.75M | 15.75M | 15.75M |
| Basic Shares Outstanding | 1.44M | 11.25M | 15.75M | 15.75M | 15.75M |
| Dividend Payout Ratio | - | - | - | - | - |
Liquidation and deal failure
As indicated by the most recent quarterly filings, IBAC's SG&A expenses surged to $748.2K in 2026Q2, representing a significant departure from the historical quarterly average of approximately $130K, which suggests an intensification of due diligence or legal activities as the search period for a target nears expiration.
The sharp spike in operating costs during the second quarter of 2026 implies that the company is incurring substantial professional fees, likely related to late-stage acquisition efforts. Investors should monitor whether this elevated burn rate is sustainable given the limited cash reserves, as it may necessitate additional sponsor capital injections to avoid insolvency before a merger is finalized.
Based on the reported financial statements, IBAC's net income has historically been driven by non-operating items rather than core operations, with net income swinging from a $1.1M profit in 2024Q3 to a $639.9K loss in 2026Q2, highlighting the volatility inherent in shell company accounting.
The inconsistency in net income appears to be a function of fair-value adjustments related to financial instruments or warrant liabilities rather than operational performance. This volatility obscures the underlying financial health of the entity and warrants caution, as these non-cash items do not reflect the actual cash-generating capability of the sponsor's search vehicle.
According to the income statement data, IBAC maintains zero revenue and negative operating income across all reported periods, confirming that the entity lacks any operational leverage as it remains a pre-revenue shell company awaiting a business combination to initiate its primary economic activity.
The absence of revenue means that every dollar of SG&A expense directly erodes the company's net asset value. Without a successful merger, the company's cost structure is purely a drain on capital, and there is no evidence of scaling efficiency in the current administrative-heavy expense profile.
As reported in recent filings, the combination of a $748.2K quarterly loss and a limited cash balance suggests that IBAC faces mounting pressure to secure a target, as the current trajectory may lead to a depletion of working capital before a viable acquisition can be executed.
Short-term observers might argue that the recent surge in expenses indicates imminent deal activity, yet the lack of a clear revenue-generating target suggests that the risk of liquidation is rising. Investors should consider that the 'option value' of the sponsor's network is increasingly constrained by the company's deteriorating liquidity position.
Quick answers to the most common questions about buying IBAC stock.
IB Acquisition Corp. Common Stock (IBAC) is profitable, generating $3.4M in net income for the fiscal year ending 2025.